A novel role for CD4+ T cells in the control of cachexia

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4676-4684

  Wang, Zhuangzhi ^a   Zhao, Chunfang ^a   Moya, Rosa ^a   Davies, Joanna D ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA; HERMES ANTIGEN; MUSCLE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BODY WEIGHT; CACHEXIA; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENE LOSS; HOMEOSTASIS; IMMUNOCOMPETENT CELL; IMPAIRED GLUCOSE TOLERANCE; LYMPH NODE; LYMPHOCYTOPENIA; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; SPLEEN; T CELL DEPLETION; WASTING SYNDROME; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANCER TRANSPLANTATION; HOSPITALIZATION; IMMUNOLOGY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LEWIS CARCINOMA; METABOLISM; NONOBESE DIABETIC MOUSE; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; CACHEXIA; CARCINOMA, LEWIS LUNG; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 1; FEMALE; INCIDENCE; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MUSCULAR ATROPHY; NEOPLASM TRANSPLANTATION; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS; WASTING SYNDROME;

EID: 58149277747     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4676     Document Type: Article

References (78)

1. Strawford, A., and M. Hellerstein. 1998. The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome. Semin. Oncol. 25: 76-81. (Pubitemid 28268509)
2. Grounds, M. D. 2002. Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology 3: 19-24.
3. Wallace, J. I., and R. S. Schwartz. 2002. Epidemiology of weight loss in humans with special reference to wasting in the elderly. Int. J. Cardiol. 85: 15-21.
4. Thomas, D. R. 2007. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin. Nutr. 26: 389-399.
5. Nair, K. S., G. C. Ford, K. Ekberg, E. Fernqvist-Forbes, and J. Wahren. 1995. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J. Clin. Invest. 95: 2926-2937.
6. McMichael, A. J., and S. L. Rowland-Jones. 2001. Cellular immune responses to HIV. Nature 410: 980-981.
7. Chakravarti, B., and G. N. Abraham. 1999. Aging and T-cell-mediated immunity. Mech. Ageing Dev. 108: 183-206.
8. Burns, E. A., and J. S. Goodwin. 1997. Immunodeficiency of aging. Drugs Aging 11: 374-397.
9. Jonsson, R., K. A. Brokstad, T. Hansen, T. Davies, and E. Ulvestad. 2002. The evolution and breakdown of the immune system: implications for development of autoimmune diseases. Scand. J. Immunol. 56: 323-326. (Pubitemid 35002038)
10. Jaramillo, A., B. M. Gill, and T. L. Delovitch. 1994. Insulin dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy? Life Sci. 55: 1163-1177. (Pubitemid 24290420)
11. Barrat, F., H. Haegel, A. Louise, S. Vincent-Naulleau, H. J. Boulouis, T. Neway, R. Ceredig, and C. Pilet. 1995. Quantitative and qualitative changes in CD44 and MEL-14 expression by T cells in C57BL/6 mice during aging. Res. Immunol. 146: 23-34.
12. + lymphocytes in the aged microenvironment results in a memory-enriched population. J. Immunol. 162: 711-717.
13. Donnini, A., F. Re, M. Bollettini, R. Moresi, S. Tesei, G. Bernardini, and M. Provinciali. 2005. Age-related susceptibility of naive and memory CD4 T cells to apoptosis induced by IL-2 deprivation or PHA addition. Biogerontology 6: 193-204. (Pubitemid 41131169)
14. Miller, R. A., P. Turke, C. Chrisp, J. Ruger, A. Luciano, J. Peterson, K. Chalmers, G. Gorgas, and S. VanCise. 1994. Age-sensitive T cell phenotypes covary in genetically heterogenous mice and predict early death from lymphoma. J. Gerontol. 49: 255-262.
15. Miller, R. A., C. Chrisp, and A. Galecki. 1997. CD4 memory T cell levels predict life span in genetically heterogenous mice. FASEB J. 11: 775-783.
16. + T cell lymphopenia. Immunology. In press.
17. Budd, R. C., J. C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138: 3120-3129.
18. Swain, S. L. 1994. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1: 543-552. (Pubitemid 2156900)
19. Birkeland, M. L., P. Johnson, I. S. Trowbridge, and E. Pure. 1989. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc. Natl. Acad. Sci. USA 86: 6734-6738.
20. Bottomly, K., M. Luqman, L. Greenbaum, S. Carding, J. West, T. Pasqualini, and D. B. Murphy. 1989. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur. J. Immunol. 19: 617-623. (Pubitemid 19152926)
21. + T cells. J. Immunol. 144: 3288-3295.
22. Castano, L., and G. S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 8: 647-679. (Pubitemid 20135642)
23. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291-297.
24. Kettelhut, I. C., S. S. Wing, and A. L. Goldberg. 1988. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab. Rev. 4: 751-772. (Pubitemid 19019241)
25. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51: 285-322.
26. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13. (Pubitemid 10185796)
27. Sumi, T., O. Ishiko, K. Honda, T. Yasui, and S. Ogita. 1999. Muscle cell apoptosis is responsible for the body weight loss in tumor-bearing rabbits. Osaka City Med. J. 45: 25-35.
28. Carbo, N., S. Busquets, M. van Royen, B. Alvarez, J. F. Lopez-Soriano, and J. M. Argiles. 2002. TNF-α is involved in activating DNA fragmentation in skeletal muscle. Br. J. Cancer 86: 1012-1016. (Pubitemid 34271042)
29. Busquets, S., C. Deans, M. Figueras, R. Moore-Carrasco, F. J. López-Soriano, K. C. Fearon, and J. M. Argilés. 2007. Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clin. Nutr. 26: 614-618. (Pubitemid 47618326)
30. Gu, D., and N. Sarvetnick. 1993. Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 118: 83-146
31. Downs, T. R., and W. W. Wilfinger. 1983. Fluorometric quantification of DNA in cells and tissue. Anal. Biochem. 131: 538-547.
32. Fearon, K. C., A. C. Voss, and D. S. Hustead. 2006. Cancer Cachexia Study Group: definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am. J. Clin. Nutr. 83: 1345-1350.
33. Tracey, K. J., and A. Cerami. 1989. Studies of cachexia in parasitic infection. Ann. NY Acad. Sci. 569: 211-218.
34. Hasselgren, P. O., and J. E. Fischer. 2001. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann. Surg. 233: 9-17. (Pubitemid 32042769)
35. Loprinzi, C. L., D. L. Barton, A. Jatoi, J. Sloan, J. Martenson, D. Steensma, R. Rao, P. Novotny, A. Sood, A. Grothey, et al. 2007. Symptom control trials: a 20-year experience. J. Support. Oncol. 5: 119-125, 128.
36. Jatoi, A., K. Rowland, C. L. Loprinzi, J. A. Sloan, S. R. Dakhil, N. MacDonald, B. Gagnon, P. J. Novotny, J. A. Mailliard, T. I. Bushey, et al. 2004. North Central Cancer Treatment Group: an eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J. Clin. Oncol. 22: 2469-2476. (Pubitemid 41115406)
37. Mantovani, G., A. Macciò, C. Madeddu, G. Gramignano, R. Serpe, E. Massa, M. Dessì, F. M. Tanca, E. Sanna, L. Deiana, et al. 2008. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 24: 305-313.
38. Min, B., G. Foucras, M. Meier-Schellersheim, and W. E. Paul. 2004. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc. Natl. Acad. Sci. USA 101: 3874-3879. (Pubitemid 38381070)
39. + T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J. Immunol. 171: 61-68.
40. Wojciechowski, S., P. Tripathi, T. Bourdeau, L. Acero, H. L. Grimes, J. D. Katz, F. D. Finkelman, and D. A. Hildeman. 2007. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J. Exp. Med. 204: 1665-1675. (Pubitemid 47048032)
41. Freitas, A. A., and B. B. Rocha. 1993. Lymphocyte lifespans: homeostasis, selection and competition. Immunol. Today 14: 25-29.
42. Bell, E. B., and S. M. Sparshott. 1997. The peripheral T-cell pool: regulation by non-antigen induced proliferation? Semin. Immunol. 9: 347-353.
43. Mackall, C. L., F. T. Hakim, and R. E. Gress. 1997. Restoration of T-cell homeostasis after T-cell depletion. Semin. Immunol. 9: 339-346.
44. Charlton, M., and K. S. Nair. 1998. Protein metabolism in insulin-dependent diabetes mellitus. J. Nutr. 128: 323S-327S. (Pubitemid 28090371)
45. Abu-Lebdeh, H. S., and K. S. Nair. 1996. Protein metabolism in diabetes mellitus. Baillieres Clin. Endocrinol. Metab. 10: 589-601.
46. Bennett, R. G., F. G. Hamel, and W. C. Duckworth. 2000. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome. Endocrinology 141: 2508-2517.
47. Lecker, S. H., R. T. Jagoe, A. Gilbert, M. Gomes, V. Baracos, J. Bailey, S. R. Price, W. E. Mitch, and A. L. Goldberg. 2004. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18: 39-51.
48. Gleeson, P. A., B. H. Toh, and I. R. van Driel. 1996. Organ-specific autoimmunity induced by lymphopenia. Immunol. Rev. 149: 97-125.
49. Schaller, J. G. 1975. Immunodeficiency and autoimmunity. Birth Defects Orig. Artic. Ser. 11: 173-184.
50. Barthlott, T., G. Kassiotis, and B. Stockinger. 2003. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197: 451-460. (Pubitemid 36278601)
51. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
52. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
53. + T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes 56: 1395-1402.
54. + T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes. Immunology 96: 600-605.
55. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5: 1461-1471.
56. + regulatory T cells. Nat. Immunol. 4: 330-336.
57. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
58. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199: 1401-1408. (Pubitemid 38685731)
59. Waldmann, T. A. 1989. The multi-subunit interleukin-2 receptor. Annu. Rev. Biochem. 58: 875-911.
60. Jackson, D. G., and J. I. Bell. 1990. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J. Immunol. 144: 2811-2815.
61. Surh, C. D., O. Boyman, J. F. Purton, and J. Sprent. 2006. Homeostasis of memory T cells. Immunol. Rev. 211: 154-163.
62. Ernst, B., D.-S. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181. (Pubitemid 29428810)
63. Min, B., H. Yamane, J. Hu-Li, and W. E. Paul. 2005. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J. Immunol. 174: 6039-6044. (Pubitemid 40663791)
64. Schindler, R., P. Ghezzi, and C. A. Dinarello. 1990. IL-1 induces IL-1. IV. IFN-γ suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 144: 2216-2222. (Pubitemid 20106563)
65. Ucla, C., P. Roux-Lombard, S. Fey, J. M. Dayer, and B. Mach. 1990. Interferon γ drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells. J. Clin. Invest. 85: 185-191. (Pubitemid 20030308)
66. Cederholm, T., B. Wretlind, K. Hellstrom, B. Andersson, L. Engstrom, K. Brismar, A. Scheynius, J. Forslid, and J. Palmblad. 1997. Enhanced generation of interleukins 1β and 6 may contribute to the cachexia of chronic disease. Am. J. Clin. Nutr. 65: 876-882. (Pubitemid 27111099)
67. Yasumoto, K., N. Mukaida, A. Harada, K. Kuno, M. Akiyama, E. Nakashima, N. Fujioka, M. Mai, T. Kasahara, K. Fujimoto-Ouchi, et al. 1995. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma- bearing mice. Cancer Res. 55: 921-927.
68. Mantovani, G., A. Maccio, P. Lai, E. Massa, M. Ghiani, and M. C. Santona. 1998. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine down-regulation and improvement of clinical symptoms. Crit. Rev. Oncog. 9: 99-106. (Pubitemid 29079042)
69. Strassmann, G., M. Fong, J. S. Kenney, and C. O. Jacob. 1992. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89: 1681-1684.
70. Fujimoto-Ouchi, K., S. Tamura, K. Mori, Y. Tanaka, and H. Ishitsuka. 1995. Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma. Int. J. Cancer 61: 522-528.
71. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino, Jr., and J. V. O'Connor. 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163: 1433-1450. (Pubitemid 16043463)
72. Zugmaier, G., S. Paik, G. Wilding, C. Knabbe, M. Bano, R. Lupu, B. Deschauer, S. Simpson, R. B. Dickson, and M. Lippman. 1991. Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51: 3590-3594.
73. Chuncharunee, S., C. D. Carter, K. E. Studtmann, J. Caro, R. J. Coffey, and E. N. Dessypris. 1993. Chronic administration of transforming growth factor-β suppresses erythropoietin-dependent erythropoiesis and induces tumor necrosis factor in vivo. Br. J. Haematol. 84: 374-380. (Pubitemid 23224150)
74. Sturlan, S., B. G. Beinhauer, G. Oberhuber, L. Huang, A. O. Aasen, and M. A. Rogy. 2002. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice. Anticancer Res. 22: 2547-2554. (Pubitemid 36069278)
75. Fujiki, F., N. Mukaida, K. Hirose, H. Ishida, A. Harada, S. Ohno, H. Bluethmann, M. Kawakami, M. Akiyama, S. Sone, and K. Matsushima. 1997. Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer. Cancer Res. 57: 94-99. (Pubitemid 27020335)
76. Wagner, P. D. 2008. Possible mechanisms underlying the development of cachexia in COPD. Eur. Respir. J. 31: 492-501.
77. Marcora, S. M., K. R. Chester, G. Mittal, A. B. Lemmey, and P. J. Maddison. 2006. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am. J. Clin. Nutr. 84: 1463-1472.
78. Monk, J. P., G. Phillips, R. Waite, J. Kuhn, L. J. Schaaf, G. A. Otterson, D. Guttridge, C. Rhoades, M. Shah, T. Criswell, et al. 2006. Assessment of tumor necrosis factor α blockade as an intervention to improve tolerability of doseintensive chemotherapy in cancer patients. J. Clin. Oncol. 24: 1852-1859.